Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2019-02-20 History
Report ID 57888
Drug Identification Number 02401312
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name HIKMA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 2G 0.25G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 2.25 G
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-09
Estimated end date 2019-04-01
Actual end date 2019-02-19
Shortage status Resolved
Updated date 2019-02-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-02-20 English Compare
v11 2019-02-19 French Compare
v10 2019-02-19 English Compare
v9 2018-12-12 French Compare
v8 2018-12-12 English Compare
v7 2018-12-12 English Compare
v6 2018-08-22 French Compare
v5 2018-08-22 English Compare
v4 2018-08-22 English Compare
v3 2018-08-10 French Compare
v2 2018-08-10 English Compare
v1 2018-08-10 English Compare

Showing 1 to 12 of 12